₹ 1.8 Cr
Volume Transacted
(Dec 26, 2024)
11.5 K
Stocks Traded
(Dec 26, 2024)
Last Updated on: Dec 26, 2024
Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
ISIN
INE935A01035
Last updated on: Dec 26, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
Share Price
₹ 1540.95
4.80 (0.31%)
Last updated on: Dec 26, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
26 Dec 2024 | 1540.95 | 1516.05 | 1547.55 | 1511.15 |
24 Dec 2024 | 1536.15 | 1551.2 | 1562.05 | 1530 |
23 Dec 2024 | 1549.95 | 1552.25 | 1565.95 | 1534.8 |
20 Dec 2024 | 1542.35 | 1517.25 | 1560 | 1517.25 |
19 Dec 2024 | 1540 | 1485.3 | 1550.8 | 1485.3 |
18 Dec 2024 | 1524.2 | 1529.95 | 1542 | 1510.95 |
17 Dec 2024 | 1512.6 | 1550 | 1553.8 | 1506.5 |
16 Dec 2024 | 1551.4 | 1510.8 | 1562 | 1501.5 |
13 Dec 2024 | 1517.2 | 1544.45 | 1544.45 | 1447 |
12 Dec 2024 | 1534.5 | 1544.95 | 1545 | 1527.85 |
Date | Price (₹) |
---|---|
26 Dec 2024 | 1540.95 |
24 Dec 2024 | 1536.15 |
23 Dec 2024 | 1549.95 |
20 Dec 2024 | 1542.35 |
19 Dec 2024 | 1540 |
18 Dec 2024 | 1524.2 |
17 Dec 2024 | 1512.6 |
16 Dec 2024 | 1551.4 |
13 Dec 2024 | 1517.2 |
12 Dec 2024 | 1534.5 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 26 Dec 9.00 AM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Glenmark Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Glenmark Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Glenmark Pharmaceuticals Inc. USA launches Lacosamide Oral Solution
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Lacosamide Oral Solu...
16 Dec 2024 09:06
Glenmark Pharma arm launches seizure drug in US
The newly launched drug is bioequivalent and therapeutically equivalent to the reference l...
16 Dec 2024 09:41
Glenmark Pharmaceuticals Ltd up for third straight session
Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...
03 Dec 2024 13:06
Glenmark Pharma launches Travoprost Ophthalmic Solution USP
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Travoprost Ophthalmi...
27 Nov 2024 09:12
Glenmark Pharma arm launches Travoprost Ophthalmic Solution in U.S market
Travoprost ophthalmic is used to treat glaucoma (a condition in which increased pressure i...
27 Nov 2024 09:59
Glenmark Pharmaceuticals Ltd eases for fifth straight session
Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...
18 Nov 2024 13:35
Unlimited trading starting at just Rs. 249*